Myc-CaP cell growth inhibition, suppressed clonogenic survival and G0/G1 cell cycle arrest, increased p21 and p27 expression; in vivo suppression of tumor growth, AR, HIF-1α, miR-20a, miR-21. This evidence concerns the gene HIF1A and neoplasm.